ATE96670T1 - Arzneimittel auf dextrorphanbasis zur intranasalen applikation. - Google Patents

Arzneimittel auf dextrorphanbasis zur intranasalen applikation.

Info

Publication number
ATE96670T1
ATE96670T1 AT86201655T AT86201655T ATE96670T1 AT E96670 T1 ATE96670 T1 AT E96670T1 AT 86201655 T AT86201655 T AT 86201655T AT 86201655 T AT86201655 T AT 86201655T AT E96670 T1 ATE96670 T1 AT E96670T1
Authority
AT
Austria
Prior art keywords
dextrorphane
antitussis
action
intranasal application
based pharmaceuticals
Prior art date
Application number
AT86201655T
Other languages
English (en)
Inventor
Soldato Piero Del
Silvano Casadio
Original Assignee
Prodotti Formenti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodotti Formenti filed Critical Prodotti Formenti
Application granted granted Critical
Publication of ATE96670T1 publication Critical patent/ATE96670T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT86201655T 1985-09-26 1986-09-24 Arzneimittel auf dextrorphanbasis zur intranasalen applikation. ATE96670T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22288/85A IT1187743B (it) 1985-09-26 1985-09-26 Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
EP86201655A EP0219896B1 (de) 1985-09-26 1986-09-24 Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation

Publications (1)

Publication Number Publication Date
ATE96670T1 true ATE96670T1 (de) 1993-11-15

Family

ID=11194217

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86201655T ATE96670T1 (de) 1985-09-26 1986-09-24 Arzneimittel auf dextrorphanbasis zur intranasalen applikation.

Country Status (5)

Country Link
EP (1) EP0219896B1 (de)
JP (1) JPS6272617A (de)
AT (1) ATE96670T1 (de)
DE (1) DE3689254T2 (de)
IT (1) IT1187743B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
US5179079A (en) * 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
IT1226800B (it) * 1988-09-16 1991-02-19 Prodotti Formenti Composizioni farmaceutiche orali contenenti sali di destrorfano.
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
WO2022235576A1 (en) * 2021-05-03 2022-11-10 Wang Michael Z Methods and compositions for treating depression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1121358A (en) * 1965-10-21 1968-07-24 Bristol Myers Co Aerosol manufacture
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
US4454140A (en) * 1982-09-07 1984-06-12 Hoffmann-La Roche Inc. Nasal administration of dextromethorphan
IT1164227B (it) * 1983-05-13 1987-04-08 Angeli Inst Spa Composizione farmaceutica atta alla somministrazione nasale di sali quaternari d'ammonio ed attivita' anticolinergica

Also Published As

Publication number Publication date
EP0219896A1 (de) 1987-04-29
DE3689254D1 (de) 1993-12-09
IT8522288A0 (it) 1985-09-26
IT1187743B (it) 1987-12-23
JPS6272617A (ja) 1987-04-03
DE3689254T2 (de) 1994-03-17
EP0219896B1 (de) 1993-11-03

Similar Documents

Publication Publication Date Title
ES8301632A1 (es) Un metodo, para la preparacion de una formulacion farmaceutica de un agente bioactivo polar.
NO165543C (no) Analogifremgangsmaate for fremst av terapeutisk aktiv (4r,5s,6s,8r,2's,-4's)-3- 4-(dimethylamino-carbonyl)-pyrrolidinhylthio -4-methyl-6-(1-hydroxyethyl)-1-azabicyclo- 3,2,0 hept-2-en-7-on-2-carboxylsyre i krystallinsk form.
IT8647603A0 (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
NO171209C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfinanestere
MX171191B (es) Composiciones farmaceuticas de glipizida
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
MX9203554A (es) Un dispositivo osmotico para administrar doxazosin
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
ATE60713T1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutz der oeso-gastro- duodenalen schleimhaut.
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
IT1200099B (it) Composizioni farmaceutiche somministrabili per via nasale
ATE96670T1 (de) Arzneimittel auf dextrorphanbasis zur intranasalen applikation.
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO170012C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
SE8501312D0 (sv) Etoposide oral dosage form
NO168176C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
DE3881254T2 (de) Pharmazeutische zusammensetzung.
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
IT7823016A0 (it) Composto farmaceutico di migliorata attivita' mucolitica e fluidificante delle secrezioni mucose.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties